|
[1]
|
李科汛. 胸段食管鳞癌淋巴结清扫强度与预后的相关性研究[D]: [硕士学位论文]. 成都: 电子科技大学, 2023.
|
|
[2]
|
刘欣. 基于液体活检的cfDNA甲基化在食管癌早期诊断的临床应用价值分析[D]: [硕士学位论文]. 长春: 吉林大学, 2024.
|
|
[3]
|
李昌顶. 70岁以上食管鳞癌治疗效果及预后因素比较研究[D]: [硕士学位论文]. 泸州: 西南医科大学, 2024.
|
|
[4]
|
陈令媛. 健脾消膈方联合TP方案化疗治疗中晚期食管鳞癌的临床研究[D]: [硕士学位论文]. 南京: 南京中医药大学, 2022.
|
|
[5]
|
蒋雷. 中老年患者肠道微生态与食管鳞癌的关系[D]: [硕士学位论文]. 大连: 大连医科大学, 2021.
|
|
[6]
|
潘冠华. NF-κB促进食管鳞癌血管生长和食管癌细胞增殖、侵袭的研究[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2024.
|
|
[7]
|
Qian, K., Fu, D., Jiang, B., Wang, Y., Tian, F., Song, L., et al. (2021) Mechanism of Hedyotis diffusa in the Treatment of Cervical Cancer. Frontiers in Pharmacology, 12, Article 808144. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
秦凌峰. 白花蛇舌草化学成分及药理活性研究[D]: [硕士学位论文]. 北京: 北京协和医学院, 2024.
|
|
[9]
|
Zhang, R., Ma, C., Wei, Y., Wang, X., Jia, J., Li, J., et al. (2021) Isolation, Purification, Structural Characteristics, Pharmacological Activities, and Combined Action of Hedyotis diffusa Polysaccharides: A Review. International Journal of Biological Macromolecules, 183, 119-131. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
王雪, 夏顺利, 刘景楠, 等. 白花蛇舌草总黄酮大孔树脂纯化工艺及其体内抑瘤作用的研究[J]. 中医药信息, 2021, 38(3): 16-21.
|
|
[11]
|
Huang, L., Xu, H., Wu, T. and Li, G. (2021) Hedyotis diffusa Willd. Suppresses Hepatocellular Carcinoma via Downregulating Akt/mTOR Pathways. Evidence-Based Complementary and Alternative Medicine, 2021, Article ID: 5210152. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Wu, Z., Yin, B. and You, F. (2022) Molecular Mechanism of Anti-Colorectal Cancer Effect of Hedyotis diffusa Willd and Its Extracts. Frontiers in Pharmacology, 13, Article 820474. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
徐应怡, 汪子贵, 尚瑞鹏, 等. 纳米粒递送中药活性成分在癌症治疗中的应用研究进展[J]. 天津中医药大学学报, 2025, 44(7): 661-672.
|
|
[14]
|
Vinayak, M. and Maurya, A.K. (2019) Quercetin Loaded Nanoparticles in Targeting Cancer: Recent Development. Anti-Cancer Agents in Medicinal Chemistry, 19, 1560-1576. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
程旭, 谢智锋, 施向敏, 等. 基于网络药理学和实验验证探讨槲皮素增敏乳腺癌治疗作用机制研究[J]. 现代药物与临床, 2025, 40(4): 845-853.
|
|
[16]
|
胡永进, 李凤娥. 槲皮素调节PD-1/PD-L1信号通路对胃癌细胞免疫逃逸的影响[J]. 中国免疫学杂志, 2025, 41(8): 1965-1969.
|
|
[17]
|
韩惠杰, 刘辉, 赵永波, 等. 基于网络药理学和实验验证探讨槲皮素通过p53信号通路抗结直肠癌的作用机制[J]. 山东科学, 2025, 38(1): 32-43.
|
|
[18]
|
Crombet Ramos, T., Santos Morales, O., Dy, G.K., León Monzón, K. and Lage Dávila, A. (2021) The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer. Frontiers in Oncology, 11, Article 639745. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Darmadi, D., Aminov, Z., Hjazi, A., Roopashree, R., Kazmi, S.W., Mustafa, Y.F., et al. (2024) Investigation of the Regulation of EGF Signaling by miRNAs, Delving into the Underlying Mechanism and Signaling Pathways in Cancer. Experimental Cell Research, 442, Article ID: 114267. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Luo, Y., Wang, D., Gong, T. and Zhu, J. (2016) An Updated Meta-Analysis of 37 Case-Control Studies on the Association between NFKB1-94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility. Oncotarget, 7, 58659-58670. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Voce, D.J., Schmitt, A.M., Uppal, A., McNerney, M.E., Bernal, G.M., Cahill, K.E., et al. (2014) Nfkb1 Is a Haploinsufficient DNA Damage-Specific Tumor Suppressor. Oncogene, 34, 2807-2813. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Voskarides, K. and Giannopoulou, N. (2023) The Role of TP53 in Adaptation and Evolution. Cells, 12, Article 512. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Zhong, L., Li, H., Chang, W., Ao, Y., Wen, Z. and Chen, Y. (2023) TP53 Mutations in Esophageal Squamous Cell Carcinoma. Frontiers in Bioscience-Landmark, 28, Article 219. [Google Scholar] [CrossRef] [PubMed]
|